Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach

Q1 Environmental Science
Toxicology Reports Pub Date : 2026-06-01 Epub Date: 2026-01-14 DOI:10.1016/j.toxrep.2026.102206
Nathaphat Harnkit , Tiyanee Sahad , Ittiya Noonate , Phatiphan Primpai , Sarayut Radapong , Weerachai Pipatrattanaseree , Pornchai Sincharoenpokai , Pramote Chamnanpuen
{"title":"Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach","authors":"Nathaphat Harnkit ,&nbsp;Tiyanee Sahad ,&nbsp;Ittiya Noonate ,&nbsp;Phatiphan Primpai ,&nbsp;Sarayut Radapong ,&nbsp;Weerachai Pipatrattanaseree ,&nbsp;Pornchai Sincharoenpokai ,&nbsp;Pramote Chamnanpuen","doi":"10.1016/j.toxrep.2026.102206","DOIUrl":null,"url":null,"abstract":"<div><div>The increasing global use of <em>Mitragyna speciosa</em> (Kratom) necessitates a thorough safety assessment, particularly regarding the genotoxic potential of its key alkaloids. This study employed an integrated in silico and in vitro approach to evaluate the genotoxicity of a well-characterized, semi-synthetically enhanced Kratom preparation (SKP) enriched in 7-hydroxymitragynine (7-OHMG; 56.31 % of total composition). Computational predictions using the OECD QSAR Toolbox and VEGA-QSAR platform indicated a lack of genotoxic activity for the major Kratom alkaloids (mitragynine, paynantheine, speciogynine, 7-hydroxymitragynine, and speciociliatine) across various in vitro and in vivo endpoints. However, several DNA-binding structural alerts were identified, particularly under metabolic activation, and prediction reliability ranged from low to moderate. To empirically verify these findings, an in vitro cytokinesis-block micronucleus (CBMN) assay was conducted in human TK6 cells following OECD Test Guideline 487. The extract induced concentration-dependent cytotoxicity. A statistically significant increase in micronucleus frequency was observed only at the highest concentration tested (125 µg/mL) under short-term (4 h) exposure conditions, both with and without S9 metabolic activation. Excessive cytotoxicity prevented analysis at high concentrations during long-term (24 h) exposure. Importantly, a complementary bacterial reverse mutation assay (Ames test) conducted on the identical extract showed no mutagenic activity up to 5000 µg/plate across five strains. In conclusion, while a weak positive chromosomal effect was noted at a highly cytotoxic concentration, the overall weight of evidence—including negative in silico predictions, negative Ames results, and limited in vitro micronucleus response—suggests that this 7-OHMG-enriched Kratom preparation does not present a significant genotoxic hazard under the conditions tested. This study underscores the value of a combined computational and experimental workflow for the robust genotoxicity assessment of complex natural products.</div></div>","PeriodicalId":23129,"journal":{"name":"Toxicology Reports","volume":"16 ","pages":"Article 102206"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214750026000089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Environmental Science","Score":null,"Total":0}
引用次数: 0

Abstract

The increasing global use of Mitragyna speciosa (Kratom) necessitates a thorough safety assessment, particularly regarding the genotoxic potential of its key alkaloids. This study employed an integrated in silico and in vitro approach to evaluate the genotoxicity of a well-characterized, semi-synthetically enhanced Kratom preparation (SKP) enriched in 7-hydroxymitragynine (7-OHMG; 56.31 % of total composition). Computational predictions using the OECD QSAR Toolbox and VEGA-QSAR platform indicated a lack of genotoxic activity for the major Kratom alkaloids (mitragynine, paynantheine, speciogynine, 7-hydroxymitragynine, and speciociliatine) across various in vitro and in vivo endpoints. However, several DNA-binding structural alerts were identified, particularly under metabolic activation, and prediction reliability ranged from low to moderate. To empirically verify these findings, an in vitro cytokinesis-block micronucleus (CBMN) assay was conducted in human TK6 cells following OECD Test Guideline 487. The extract induced concentration-dependent cytotoxicity. A statistically significant increase in micronucleus frequency was observed only at the highest concentration tested (125 µg/mL) under short-term (4 h) exposure conditions, both with and without S9 metabolic activation. Excessive cytotoxicity prevented analysis at high concentrations during long-term (24 h) exposure. Importantly, a complementary bacterial reverse mutation assay (Ames test) conducted on the identical extract showed no mutagenic activity up to 5000 µg/plate across five strains. In conclusion, while a weak positive chromosomal effect was noted at a highly cytotoxic concentration, the overall weight of evidence—including negative in silico predictions, negative Ames results, and limited in vitro micronucleus response—suggests that this 7-OHMG-enriched Kratom preparation does not present a significant genotoxic hazard under the conditions tested. This study underscores the value of a combined computational and experimental workflow for the robust genotoxicity assessment of complex natural products.
富含7-羟基米特拉甘氨酸的Kratom制剂的遗传毒性风险评估:一种集成的体外和体外方法
随着米特拉基纳(Kratom)在全球的使用日益增加,需要对其进行彻底的安全性评估,特别是对其主要生物碱的遗传毒性潜力进行评估。本研究采用硅内和体外结合的方法,对一种表征良好、富含7-羟基米特ragynine (7-OHMG;占总成分56.31 %)的半合成增强Kratom制剂(SKP)的遗传毒性进行了评价。使用OECD QSAR工具箱和VEGA-QSAR平台的计算预测表明,Kratom主要生物碱(米特拉吉碱、paynantheine、特特拉吉碱、7-羟基米特拉吉碱和特特拉吉碱)在各种体外和体内终点缺乏遗传毒性活性。然而,几个dna结合结构警报被确定,特别是在代谢激活下,预测可靠性范围从低到中等。为了从经验上验证这些发现,根据OECD试验指南487,在人TK6细胞中进行了体外细胞动力学阻断微核(CBMN)测定。提取物诱导浓度依赖性细胞毒性。在短期(4 h)暴露条件下,无论是否有S9代谢激活,仅在最高浓度(125µg/mL)下观察到微核频率有统计学意义的增加。在长期(24 h)暴露期间,过量的细胞毒性阻止了高浓度的分析。重要的是,在相同的提取物上进行的互补细菌反向突变试验(Ames试验)显示,在5000 μ g/板的情况下,5株菌株没有诱变活性。总之,虽然在高细胞毒性浓度下发现了微弱的阳性染色体效应,但证据的总体重量-包括阴性的硅预测,阴性的Ames结果和有限的体外微核反应-表明,在测试条件下,这种富含7- ohmg的Kratom制剂不存在显著的遗传毒性危害。这项研究强调了计算和实验相结合的工作流程对复杂天然产物的强大遗传毒性评估的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Toxicology Reports
Toxicology Reports Environmental Science-Health, Toxicology and Mutagenesis
CiteScore
7.60
自引率
0.00%
发文量
228
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书